Γ-sarcoglycan Deficiency Muscular Dystrophy in Two Adults
نویسندگان
چکیده
Department of Pediatric Neurology, Chang Gung Children’s Hospital, Taoyuan; and Department of Neurology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan. Received: 29 November 1999. Revised: 30 December 1999. Accepted: 7 March 2000. Reprint requests and correspondence to: Dr. Long-Sun Ro, Department of Neurology, Chang Gung Memorial Hospital, and Chang Gung University, 199 Tung-Hwa North Road, Taipei, Taiwan. γ-SARCOGLYCAN DEFICIENCY MUSCULAR DYSTROPHY IN TWO ADULTS
منابع مشابه
Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse
Muscular dystrophy is characterized by progressive skeletal muscle weakness and dystrophic muscle exhibits degeneration and regeneration of muscle cells, inflammation and fibrosis. Skeletal muscle fibrosis is an excessive deposition of components of the extracellular matrix including an accumulation of Collagen VI. We hypothesized that a reduction of Collagen VI in a muscular dystrophy model th...
متن کاملA cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families.
Limb-girdle muscular dystrophies constitute a broad range of clinical and genetic entities. We have evaluated 38 autosomal recessive limb-girdle muscular dystrophy (LGMD2) families by linkage analysis for the known loci of LGMD2A-F and protein studies using immunofluorescence and western blotting of the sarcoglycan complex. One index case in each family was investigated thoroughly. The age of o...
متن کاملA phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
γ-Sarcoglycanopathy or limb girdle muscular dystrophy type 2C is an untreatable disease caused by autosomal recessively inherited mutations of the γ-sarcoglycan gene. Nine non-ambulatory patients (two males, seven females, mean age 27 years; range 16-38 years) with del525T homozygous mutation of the γ-sarcoglycan gene and no γ-sarcoglycan immunostaining on muscle biopsy were divided into three ...
متن کاملReengineering a transmembrane protein to treat muscular dystrophy using exon skipping.
Exon skipping uses antisense oligonucleotides as a treatment for genetic diseases. The antisense oligonucleotides used for exon skipping are designed to bypass premature stop codons in the target RNA and restore reading frame disruption. Exon skipping is currently being tested in humans with dystrophin gene mutations who have Duchenne muscular dystrophy. For Duchenne muscular dystrophy, the rat...
متن کاملGenetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.
BACKGROUND The autosomal recessive limb-girdle muscular dystrophies (LGMDs) are a group of genetically heterogeneous muscle diseases characterised by progressive proximal limb muscle weakness. Six different loci have been mapped and pathogenetic mutations in the genes encoding the sarcoglycan complex components (alpha-, beta-, gamma-, and delta-sarcoglycan) have been documented. LGMD patients a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002